IPO Oxford Nanopore Technologies to Raise £300M in IPO, Including £150M Investment by Oracle Oracle and Oxford Nanopore will also collaborate on integrating sequencing data with Oracle's cloud computing infrastructure and life sciences solutions. Ginkgo Bioworks to Go Public With $1.63B in Proceeds From SPAC Merger The company originally announced its intention to go public through the merger with Soaring Eagle in May and will begin trading on the NYSE on Friday. Oxford Nanopore Technologies Registers for IPO on London Stock Exchange For the first half of 2021, life science research tools (LSRT) revenues more than doubled year over year while COVID testing revenues declined 72 percent. Trading Plans Reuters reports that Oxford Nanopore has released plans to be traded on the London stock exchange. Cue Health Files for IPO for up to $100M The company developed its portable Cue Integrated Care Platform for molecular SARS-CoV-2 testing and received an EUA for its test in June 2020. Aug 27, 2021 SeqLL to Go Public in $13M IPO Jul 23, 2021 Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships Jul 23, 2021 Cytek Biosciences Prices $200M Initial Public Offering Jul 19, 2021 Sophia Genetics Increases IPO Target to $221M Jul 6, 2021 Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare Jul 2, 2021 Caribou Biosciences Files for $100M IPO Jun 23, 2021 Codex DNA Closes $122.7M IPO May 27, 2021 Singular Genomics Systems Raises $258M in Upsized IPO May 24, 2021 Singular Genomics Ups IPO Target to $187M May 12, 2021 Sequencing Startup Singular Genomics Files for $100M IPO Apr 28, 2021 Post-IPO, Talis Biomedical Looks Toward Expanding Infectious Disease Test Portfolio Premium Mar 30, 2021 Oxford Nanopore Technologies to File for IPO in Second Half of 2021 Mar 12, 2021 Prometheus Biosciences Prices Upsized $190M IPO Mar 3, 2021 Olink Files For Public Offering in US Feb 26, 2021 Genomics Firms Taking Advantage of SPACs Trend to Go Public Faster Premium Feb 19, 2021 NRGene Looks to Royalty-Based Partnerships in Wake of IPO Premium Feb 18, 2021 Cancer Screening Test Developer New Horizon Health Goes Public in Hong Kong Feb 18, 2021 Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO Feb 5, 2021 At-Home Infectious Disease Test Developer Lucira Health Goes Public at $17 Per Share Jan 26, 2021 NRGene Completes $30.6M IPO Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.